{"id":3764,"date":"2021-05-20T17:45:00","date_gmt":"2021-05-20T15:45:00","guid":{"rendered":"https:\/\/www.maunakeatech.com\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\/"},"modified":"2024-08-02T12:38:57","modified_gmt":"2024-08-02T10:38:57","slug":"mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi","status":"publish","type":"post","link":"https:\/\/www.maunakeatech.com\/fr\/actualites\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\/","title":{"rendered":"Mauna Kea Technologies annonce la tenue de 7 pr\u00e9sentations soulignant la valeur clinique de Cellvizio\u00ae dans l’\u00e9valuation des maladies gastro intestinales \u00e0 la Digestive Disease Week\u00ae 2021 Virtuelle\u2122"},"content":{"rendered":"

Nouvelle Validation de l'impact potentiel de l'utilisation de Cellvizio sur la prise en charge des patients et sur l'amélioration des résultats dans de multiples indications gastro-intestinales <\/i><\/b><\/p>\n

Mauna Kea Technologies annonce aujourd'hui la tenue de 7 présentations portant sur le Cellvizio®<\/sup> au cours de la conférence virtuelle Digestive Disease Week®<\/sup> (DDW), qui se tiendra du 21 au 23 mai. Ces présentations portent sur l'oesophage de Barrett (BE), les maladies inflammatoires de l'intestin (IBD), le syndrome du côlon irritable (IBS) et les allergies alimentaires associées, les kystes pancréatiques et d'autres maladies gastro-intestinales. Les études mettent l’accent sur l’impact potentiel de l’utilisation du Cellvizio dans la prise en charge des patients et l’amélioration des résultats. <\/p>\n

"L’imagerie in vivo <\/i>en temps réel avec Cellvizio est une fois de plus au centre de la Digestive Disease Week®<\/sup>, comme en témoignent les nombreuses études de grande qualité présentées cette année", déclare Rob Gershon directeur général de Mauna Kea Technologies. "Nous sommes ravis de voir le nombre et la diversité des études présentées qui démontrent comment l'utilisation du Cellvizio peut avoir un impact positif sur la prise en charge des patients et améliorer les résultats dans les procédures relatives àl'œsophage de Barrett, auxkystes pancréatiques et auxmaladies inflammatoires de l'intestin, et qui soulignent le nouveau rôle important que le Cellvizio pourrait jouer dans la prise en charge des patients souffrant du syndrome du côlon irritable, un trouble fonctionnel chronique du système gastro-intestinal qui touche environ 9,2% de la population mondiale1<\/sup>."<\/p>\n

Présentations clés <\/b>(<\/b>par ordre chronologique<\/b>)<\/b>: <\/b><\/p>\n

CONFOCAL LASER ENDOMICROSCOPY IN THE COLONIC MUCOSA OF PATIENTS WITH DIVERTICULAR DISEASE: INTERIM RESULTS <\/b><\/a>
\nPrésentation #156 
\nVendredi 21 Mai entre 1:47 – 1:53 p.m. ET 
\nAuteur \/ Présentateur: Miguel Puga-Tejada, Instituto Ecuatoriano de Enfermedades Digestiva, Ecuador <\/p>\n

ACCURACY AND AGREEMENT OF AN INTERNATIONAL PANEL FOR THE DIAGNOSIS OF PANCREATIC CYSTIC LESIONS USING EUS-GUIDED NEEDLE-BASED CONFOCAL LASER ENDOMICROSCOPY <\/b><\/a>
\nPrésentation #78 
\nVendredi 21 Mai entre 2:02 – 2:16 p.m. ET 
\nAuteur \/ Présentateur: Jorge Machicado, Mayo Clinic Health System, Eau Claire, Wisconsin, United States <\/p>\n

CONFOCAL LASER ENDOMICROSCOPY IN COMBINATION WITH MOLECULAR BIOMARKERS FOR THE DIAGNOSIS OF INCONSPICUOUS DYSPLASIA IN BARRETT'S ESOPHAGUS: A RANDOMISED CROSS-OVER TRIAL <\/b><\/a>
\nPrésentation #227 
\nVendredi 21 Mai entre 1:47 – 1:53 p.m. ET 
\nAuteur \/ Présentateur: Mathew Vithayathil, MRC Cancer Unit, University of Cambridge, Redhill, United Kingdom <\/p>\n

FOOD ALLERGY SENSITIVITY TEST (FAST) WITH ENDOMICROSCOPY OF THE DUODENUM ENABLES TAILORED EXCLUSION DIET IN PATIENTS WITH IRRITABLE BOWEL SYNDRO<\/b><\/a>
\nPrésentation #819 
\nDimanche 23 Mai entre 4:08 – 4:16 p.m. ET 
\nAuteur \/ Présentateur: Ralf Kiesslich, HELIOS Dr Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Hessen, Germany<\/p>\n

Posters clés (par ordre chronologique): <\/p>\n

RESPONSE TO BIOLOGICS IN IBD PATIENTS ASSESSED BY COMPUTERIZED IMAGE ANALYSIS OF PROBE BASED CONFOCAL LASER ENDOMICROSCOPY WITH MOLECULAR LABELING<\/a> <\/b>
\nPoster #Fr596 
\nVendredi 21 Mai entre 12:15 – 1:00 p.m. ET 
\nAuteur \/ Présentateur: Marietta Iacucci, Institute Translational of Medicine, Institute of Immunology and Immunotherapy and NIHR Birmingham Biomedical Research Centre, University Hospitals NHS Foundation Trust and University of Birmingham, Birmingham, UK, Birmingham, United Kingdom <\/p>\n

PROBE BASED CONFOCAL ENDOMICROSCOPY MAY INCREASE DETECTION OF LOW GRADE DYSPLASIA IN MALE VETERANS PREVIOUSLY DIAGNOSED WITH NON DYSPLASTIC SHORT SEGMENT BARRETT'S ESOPHAGUS UNDERGOING SURVEILLANCE <\/b><\/a>
\nPoster #Fr223 
\nVendredi 21 Mai entre 12:15 – 1:00 p.m. ET 
\nAuteur \/ Présentateur: Karen Chang, University of California System, Oakland, California, United States <\/p>\n

DEVELOPMENT OF CONFOCAL ENDOMICROSCOPY CRITERIA FOR EARLY SIGNET-RING CELL CARCINOMA IN PATIENTS WITH HEREDITARY DIFFUSE GASTRIC CANCER SYNDROME <\/b><\/a>
\nPoster # Su585 
\nDimanche 23 Mai entre 12:15 – 1:00 p.m. ET 
\nAuteur \/ Présentateur: Nastazja Dagny Pilonis, Department of Gastroenterological Oncology, Maria-Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland, Warsaw, Poland; MRC Cancer Unit, Cambridge, United Kingdom <\/p>\n

Les visiteurs sont également invités à visiter notre page virtuell<\/b>e: <\/b>https:\/\/www.landing.maunakeatech.com\/en\/ddw-2021 <\/b><\/a><\/p>\n

\n

1. Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020 Oct;5(10):908-917. doi: 10.1016\/S2468-1253(20)30217-X. Epub 2020 Jul 20. Erratum in: Lancet Gastroenterol Hepatol. 2020 Dec;5(12):e8. PMID: 32702295.  <\/span><\/p>\n

<\/p>\n

VOIR LE COMMUNIQU\u00c9 DE PRESSE<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"

Nouvelle Validation de l'impact potentiel de l'utilisation de Cellvizio sur la prise en charge des patients et sur l'amélioration des résultats dans de multiples indications gastro-intestinales  Mauna Kea Technologies annonce aujourd'hui la tenue de 7 présentations portant sur le Cellvizio® au cours de la conférence virtuelle Digestive Disease Week® (DDW), qui se tiendra du 21 au […]<\/p>\n","protected":false},"author":6,"featured_media":3765,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[29],"tags":[],"class_list":["post-3764","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-actualites"],"yoast_head":"\nMauna Kea Technologies annonce la tenue de 7 pr\u00e9sentations soulignant la valeur clinique de Cellvizio\u00ae dans l'\u00e9valuation des maladies gastro intestinales \u00e0 la Digestive Disease Week\u00ae 2021 Virtuelle\u2122 - Mauna Kea Technologies<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.maunakeatech.com\/fr\/actualites\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mauna Kea Technologies annonce la tenue de 7 pr\u00e9sentations soulignant la valeur clinique de Cellvizio\u00ae dans l'\u00e9valuation des maladies gastro intestinales \u00e0 la Digestive Disease Week\u00ae 2021 Virtuelle\u2122 - Mauna Kea Technologies\" \/>\n<meta property=\"og:description\" content=\"Nouvelle Validation de l'impact potentiel de l'utilisation de Cellvizio sur la prise en charge des patients et sur l'amélioration des résultats dans de multiples indications gastro-intestinales  Mauna Kea Technologies annonce aujourd'hui la tenue de 7 présentations portant sur le Cellvizio® au cours de la conférence virtuelle Digestive Disease Week® (DDW), qui se tiendra du 21 au […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.maunakeatech.com\/fr\/actualites\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\/\" \/>\n<meta property=\"og:site_name\" content=\"Mauna Kea Technologies\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/maunakeatech\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-20T15:45:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-08-02T10:38:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/4a6cae4837d3d09a6763840beac731711052123e.png\" \/>\n\t<meta property=\"og:image:width\" content=\"330\" \/>\n\t<meta property=\"og:image:height\" content=\"192\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Zina\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@maunakeatech\" \/>\n<meta name=\"twitter:site\" content=\"@maunakeatech\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Zina\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/fr\\\/actualites\\\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/fr\\\/actualites\\\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\\\/\"},\"author\":{\"name\":\"Zina\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/#\\\/schema\\\/person\\\/f7b9fab57af781ddbbb4933c3f16a4ac\"},\"headline\":\"Mauna Kea Technologies annonce la tenue de 7 pr\u00e9sentations soulignant la valeur clinique de Cellvizio\u00ae dans l’\u00e9valuation des maladies gastro intestinales \u00e0 la Digestive Disease Week\u00ae 2021 Virtuelle\u2122\",\"datePublished\":\"2021-05-20T15:45:00+00:00\",\"dateModified\":\"2024-08-02T10:38:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/fr\\\/actualites\\\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\\\/\"},\"wordCount\":824,\"image\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/fr\\\/actualites\\\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.maunakeatech.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/4a6cae4837d3d09a6763840beac731711052123e.png\",\"articleSection\":[\"Actualit\u00e9s\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/fr\\\/actualites\\\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\\\/\",\"url\":\"https:\\\/\\\/www.maunakeatech.com\\\/fr\\\/actualites\\\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\\\/\",\"name\":\"Mauna Kea Technologies annonce la tenue de 7 pr\u00e9sentations soulignant la valeur clinique de Cellvizio\u00ae dans l'\u00e9valuation des maladies gastro intestinales \u00e0 la Digestive Disease Week\u00ae 2021 Virtuelle\u2122 - Mauna Kea Technologies\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/fr\\\/actualites\\\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/fr\\\/actualites\\\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.maunakeatech.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/4a6cae4837d3d09a6763840beac731711052123e.png\",\"datePublished\":\"2021-05-20T15:45:00+00:00\",\"dateModified\":\"2024-08-02T10:38:57+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/#\\\/schema\\\/person\\\/f7b9fab57af781ddbbb4933c3f16a4ac\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/fr\\\/actualites\\\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.maunakeatech.com\\\/fr\\\/actualites\\\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/fr\\\/actualites\\\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.maunakeatech.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/4a6cae4837d3d09a6763840beac731711052123e.png\",\"contentUrl\":\"https:\\\/\\\/www.maunakeatech.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/4a6cae4837d3d09a6763840beac731711052123e.png\",\"width\":330,\"height\":192},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/fr\\\/actualites\\\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.maunakeatech.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mauna Kea Technologies annonce la tenue de 7 pr\u00e9sentations soulignant la valeur clinique de Cellvizio\u00ae dans l’\u00e9valuation des maladies gastro intestinales \u00e0 la Digestive Disease Week\u00ae 2021 Virtuelle\u2122\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/#website\",\"url\":\"https:\\\/\\\/www.maunakeatech.com\\\/\",\"name\":\"Mauna Kea Technologies\",\"description\":\"See Cells. Change Lives.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.maunakeatech.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.maunakeatech.com\\\/#\\\/schema\\\/person\\\/f7b9fab57af781ddbbb4933c3f16a4ac\",\"name\":\"Zina\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/61415c1e8b7bff7dd609fefc94ebe8063a2b99bea8a31140e2e3398e146975ac?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/61415c1e8b7bff7dd609fefc94ebe8063a2b99bea8a31140e2e3398e146975ac?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/61415c1e8b7bff7dd609fefc94ebe8063a2b99bea8a31140e2e3398e146975ac?s=96&d=mm&r=g\",\"caption\":\"Zina\"},\"url\":\"https:\\\/\\\/www.maunakeatech.com\\\/fr\\\/author\\\/zina\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mauna Kea Technologies annonce la tenue de 7 pr\u00e9sentations soulignant la valeur clinique de Cellvizio\u00ae dans l'\u00e9valuation des maladies gastro intestinales \u00e0 la Digestive Disease Week\u00ae 2021 Virtuelle\u2122 - Mauna Kea Technologies","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.maunakeatech.com\/fr\/actualites\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\/","og_locale":"fr_FR","og_type":"article","og_title":"Mauna Kea Technologies annonce la tenue de 7 pr\u00e9sentations soulignant la valeur clinique de Cellvizio\u00ae dans l'\u00e9valuation des maladies gastro intestinales \u00e0 la Digestive Disease Week\u00ae 2021 Virtuelle\u2122 - Mauna Kea Technologies","og_description":"Nouvelle Validation de l'impact potentiel de l'utilisation de Cellvizio sur la prise en charge des patients et sur l'amélioration des résultats dans de multiples indications gastro-intestinales  Mauna Kea Technologies annonce aujourd'hui la tenue de 7 présentations portant sur le Cellvizio® au cours de la conférence virtuelle Digestive Disease Week® (DDW), qui se tiendra du 21 au […]","og_url":"https:\/\/www.maunakeatech.com\/fr\/actualites\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\/","og_site_name":"Mauna Kea Technologies","article_publisher":"https:\/\/www.facebook.com\/maunakeatech\/","article_published_time":"2021-05-20T15:45:00+00:00","article_modified_time":"2024-08-02T10:38:57+00:00","og_image":[{"width":330,"height":192,"url":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/4a6cae4837d3d09a6763840beac731711052123e.png","type":"image\/png"}],"author":"Zina","twitter_card":"summary_large_image","twitter_creator":"@maunakeatech","twitter_site":"@maunakeatech","twitter_misc":{"\u00c9crit par":"Zina","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.maunakeatech.com\/fr\/actualites\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\/#article","isPartOf":{"@id":"https:\/\/www.maunakeatech.com\/fr\/actualites\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\/"},"author":{"name":"Zina","@id":"https:\/\/www.maunakeatech.com\/#\/schema\/person\/f7b9fab57af781ddbbb4933c3f16a4ac"},"headline":"Mauna Kea Technologies annonce la tenue de 7 pr\u00e9sentations soulignant la valeur clinique de Cellvizio\u00ae dans l’\u00e9valuation des maladies gastro intestinales \u00e0 la Digestive Disease Week\u00ae 2021 Virtuelle\u2122","datePublished":"2021-05-20T15:45:00+00:00","dateModified":"2024-08-02T10:38:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.maunakeatech.com\/fr\/actualites\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\/"},"wordCount":824,"image":{"@id":"https:\/\/www.maunakeatech.com\/fr\/actualites\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\/#primaryimage"},"thumbnailUrl":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/4a6cae4837d3d09a6763840beac731711052123e.png","articleSection":["Actualit\u00e9s"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.maunakeatech.com\/fr\/actualites\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\/","url":"https:\/\/www.maunakeatech.com\/fr\/actualites\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\/","name":"Mauna Kea Technologies annonce la tenue de 7 pr\u00e9sentations soulignant la valeur clinique de Cellvizio\u00ae dans l'\u00e9valuation des maladies gastro intestinales \u00e0 la Digestive Disease Week\u00ae 2021 Virtuelle\u2122 - Mauna Kea Technologies","isPartOf":{"@id":"https:\/\/www.maunakeatech.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.maunakeatech.com\/fr\/actualites\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\/#primaryimage"},"image":{"@id":"https:\/\/www.maunakeatech.com\/fr\/actualites\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\/#primaryimage"},"thumbnailUrl":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/4a6cae4837d3d09a6763840beac731711052123e.png","datePublished":"2021-05-20T15:45:00+00:00","dateModified":"2024-08-02T10:38:57+00:00","author":{"@id":"https:\/\/www.maunakeatech.com\/#\/schema\/person\/f7b9fab57af781ddbbb4933c3f16a4ac"},"breadcrumb":{"@id":"https:\/\/www.maunakeatech.com\/fr\/actualites\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.maunakeatech.com\/fr\/actualites\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.maunakeatech.com\/fr\/actualites\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\/#primaryimage","url":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/4a6cae4837d3d09a6763840beac731711052123e.png","contentUrl":"https:\/\/www.maunakeatech.com\/wp-content\/uploads\/2024\/08\/4a6cae4837d3d09a6763840beac731711052123e.png","width":330,"height":192},{"@type":"BreadcrumbList","@id":"https:\/\/www.maunakeatech.com\/fr\/actualites\/mauna-kea-technologies-annonce-la-tenue-de-7-presentations-soulignant-la-valeur-clinique-de-cellvizio-dans-levaluation-des-maladies-gastro-intestinales-a-la-digestive-disease-week-2021-vi\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.maunakeatech.com\/"},{"@type":"ListItem","position":2,"name":"Mauna Kea Technologies annonce la tenue de 7 pr\u00e9sentations soulignant la valeur clinique de Cellvizio\u00ae dans l’\u00e9valuation des maladies gastro intestinales \u00e0 la Digestive Disease Week\u00ae 2021 Virtuelle\u2122"}]},{"@type":"WebSite","@id":"https:\/\/www.maunakeatech.com\/#website","url":"https:\/\/www.maunakeatech.com\/","name":"Mauna Kea Technologies","description":"See Cells. Change Lives.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.maunakeatech.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.maunakeatech.com\/#\/schema\/person\/f7b9fab57af781ddbbb4933c3f16a4ac","name":"Zina","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/61415c1e8b7bff7dd609fefc94ebe8063a2b99bea8a31140e2e3398e146975ac?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/61415c1e8b7bff7dd609fefc94ebe8063a2b99bea8a31140e2e3398e146975ac?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/61415c1e8b7bff7dd609fefc94ebe8063a2b99bea8a31140e2e3398e146975ac?s=96&d=mm&r=g","caption":"Zina"},"url":"https:\/\/www.maunakeatech.com\/fr\/author\/zina\/"}]}},"_links":{"self":[{"href":"https:\/\/www.maunakeatech.com\/fr\/wp-json\/wp\/v2\/posts\/3764","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.maunakeatech.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.maunakeatech.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.maunakeatech.com\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.maunakeatech.com\/fr\/wp-json\/wp\/v2\/comments?post=3764"}],"version-history":[{"count":1,"href":"https:\/\/www.maunakeatech.com\/fr\/wp-json\/wp\/v2\/posts\/3764\/revisions"}],"predecessor-version":[{"id":5355,"href":"https:\/\/www.maunakeatech.com\/fr\/wp-json\/wp\/v2\/posts\/3764\/revisions\/5355"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.maunakeatech.com\/fr\/wp-json\/wp\/v2\/media\/3765"}],"wp:attachment":[{"href":"https:\/\/www.maunakeatech.com\/fr\/wp-json\/wp\/v2\/media?parent=3764"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.maunakeatech.com\/fr\/wp-json\/wp\/v2\/categories?post=3764"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.maunakeatech.com\/fr\/wp-json\/wp\/v2\/tags?post=3764"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}